4751 - 4775 of 7877 Results
Title
Year
-
OPENTitle: Freezing of Gait and Its Levodopa ParadoxJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 3Start Page: 287End Page: 287Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4006Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/225524/225524.pdfCitation Count: 42
- Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study2019OPENTitle: Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 45Issue #: 4Start Page: 632End Page: 640Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-019-0589-zBest OA location URL: https://www.nature.com/articles/s41386-019-0589-z.pdfCitation Count: 53
- The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease2019RESTRICTEDTitle: The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 3Start Page: 295End Page: 295Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.3983Citation Count: 12
-
RESTRICTEDTitle: Movement disorders in 2019: from antibodies to lifestyle interventionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 10End Page: 12Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30438-7Citation Count: 1
-
RESTRICTEDTitle: Multiple sclerosis in 2019: predicting progressionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7Citation Count: 1
- Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review2019RESTRICTEDTitle: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 129End Page: 139Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12874Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12874Citation Count: 27
- Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study2019RESTRICTEDTitle: Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 51End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.008Citation Count: 26
-
OPENTitle: Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 577Issue #: 7788Start Page: 103End Page: 108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-019-1828-5Best OA location URL: https://europepmc.org/articles/pmc6930849?pdf=renderCitation Count: 240
-
OPENTitle: PINK1 phosphorylates ubiquitin predominantly in astrocytesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0101-9Best OA location URL: https://www.nature.com/articles/s41531-019-0101-9.pdfCitation Count: 32
-
OPENTitle: Sex Differences in Cognitive Changes in De Novo Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 26Issue #: 2Start Page: 241End Page: 249Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617719001085Best OA location URL: https://europepmc.org/articles/pmc7282562?pdf=renderCitation Count: 10
- The Role of the Cerebellum in Degenerative Ataxias and Essential Tremor: Insights From Noninvasive Modulation of Cerebellar Activity2019RESTRICTEDTitle: The Role of the Cerebellum in Degenerative Ataxias and Essential Tremor: Insights From Noninvasive Modulation of Cerebellar ActivityJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 2Start Page: 215End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27919Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27919Citation Count: 47
- Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study2019RESTRICTEDTitle: Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 135End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30396-5Citation Count: 93
- Experience and Impact of OFF Periods in Parkinson’s Disease: A Survey of Physicians, Patients, and Carepartners2019RESTRICTEDTitle: Experience and Impact of OFF Periods in Parkinson’s Disease: A Survey of Physicians, Patients, and CarepartnersJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 1Start Page: 315End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-191785Citation Count: 7
-
OPENTitle: Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next StepsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 1Start Page: 19End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191854Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191854?id=journal-of-parkinsons-disease%2Fjpd191854Citation Count: 25
- Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs2019OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939141Citation Count: 14
- LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients2019OPENTitle: LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patientsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-13413-wBest OA location URL: https://www.nature.com/articles/s41467-019-13413-w.pdfCitation Count: 145
-
RESTRICTEDTitle: Targeting Alpha-Synuclein as a Therapy for Parkinson’s DiseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2019.00299Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2019.00299/pdfCitation Count: 217
-
OPENTitle: Cerebellar Deep Brain Stimulation for Acquired HemidystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12876Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12876Citation Count: 45
- Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease2019RESTRICTEDTitle: Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 457End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27928Citation Count: 50
- Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta‐Analyses2019RESTRICTEDTitle: Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta‐AnalysesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 523End Page: 536Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27936Citation Count: 54
- Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration2019OPENTitle: Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegenerationJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: 1Start Page: 1679End Page: 1694Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.201900567rrBest OA location URL: https://europepmc.org/articles/pmc7212500?pdf=renderCitation Count: 80
-
RESTRICTEDTitle: Suicidal risk and demoralization in Parkinson diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 4Start Page: 966End Page: 974Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-019-09632-2Citation Count: 25
- Differences in topological progression profile among neurodegenerative diseases from imaging data2019OPENTitle: Differences in topological progression profile among neurodegenerative diseases from imaging dataJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.49298Best OA location URL: https://doi.org/10.7554/elife.49298Citation Count: 10
-
OPENTitle: Risks and benefits of unapproved disease-modifying treatments for neurodegenerative diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008699Best OA location URL: https://europepmc.org/articles/pmc7011691?pdf=renderCitation Count: 29
- Short latency cortical evoked potentials elicited by subthalamic nucleus deep brain stimulation: Commentary and results from paired pulse studies2019RESTRICTEDTitle: Short latency cortical evoked potentials elicited by subthalamic nucleus deep brain stimulation: Commentary and results from paired pulse studiesJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 131Issue #: 2Start Page: 465End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2019.11.015Citation Count: 8